(Q73276431)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

In vivo development of decreased susceptibility to vancomycin in clinical isolates of methicillin-resistant Staphylococcus aureus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

main subject

Staphylococcus aureus

1 reference

methicillin-resistant Staphylococcus aureus

inferred from title

1 reference

1 reference

Y Sugino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Y Iinumab

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Ichiyama

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Y Ito

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Ohkawa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

N Nakashima

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K Shimokata

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Y Hasegawa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109014%20AND%20SRC:MED&resulttype=core&format=json

Diagnostic Microbiology and Infectious Disease

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

159-167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109014%20AND%20SRC:MED&resulttype=core&format=json

Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcus aureus

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Emergence of teicoplanin-resistant coagulase-negative staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Decreased susceptibility to antibiotic killing of a stable small colony variant of Staphylococcus aureus in fluid phase and on fibronectin-coated surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Expression and detection of hetero-vancomycin resistance in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Genomic DNA fingerprinting by pulsed-field gel electrophoresis as an epidemiological marker for study of nosocomial infections caused by methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Tolerance of Staphylococcus epidermidis grown from indwelling vascular catheters to antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Emergence of vancomycin resistance in coagulase-negative staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

A highly vancomycin-resistant laboratory mutant of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

Bacteremia caused by staphylococci with inducible vancomycin heteroresistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900186-3

7 January 2021

10.1016/S0732-8893(00)00186-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference